Skip to main content
Premium Trial:

Request an Annual Quote

Paired Ends: May 24, 2011


Andy Watson, formerly the vice president of SOLiD sequencing product management at Life Technologies, is now the vice president and chief marketing officer at RainDance Technologies. Watson has over 20 years experience in developing and commercializing genomics technologies. Prior to joining LifeTech, Watson was a founder of Quantum Dot, where he held executive technical and business management roles. He also led the development of technologies and software for large scale DNA analysis at Sequana Therapeutics and at the Wellcome Trust Sanger Institute. Watson holds MA and BA degrees from King's College, Cambridge University.

Watson's replacement at Life Tech will be Graham Scott, senior manager of global marketing development for sequencing at the company.

Jeffrey Trent
, the president and research director of the Translational Genomics Research Institute, has been appointed Foreign Trade Counselor of Luxembourg in the United States. Trent is also the president and research director of Van Andel Research Institute, a nonprofit biomedical research institute. Previously, he served as the founding scientific director of the National Human Genome Research Institute. He has also held faculty positions at the University of Arizona, Arizona State University, the University of Michigan, and Johns Hopkins University. He holds a PhD in genetics from the University of Arizona.
The Scan

Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says

A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.

Genome-Wide Analysis Sheds Light on Genetics of ADHD

A genome-wide association study meta-analysis of attention-deficit hyperactivity disorder appearing in Nature Genetics links 76 genes to risk of having the disorder.

MicroRNA Cotargeting Linked to Lupus

A mouse-based study appearing in BMC Biology implicates two microRNAs with overlapping target sites in lupus.

Enzyme Involved in Lipid Metabolism Linked to Mutational Signatures

In Nature Genetics, a Wellcome Sanger Institute-led team found that APOBEC1 may contribute to the development of the SBS2 and SBS13 mutational signatures in the small intestine.